ArticleAnnals of clinical and translational neurology2020

Targeting foam cell formation in inflammatory brain diseases by the histone modifier MS-275.

Bettina Zierfuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.